1. Gaunkar RB, Nagarsekar A, Carvalho KM, Jodalli PS,
Mascarenhas K. COVID-19 in smokeless tobacco habitués:
increased susceptibility and transmission. Cureus.
2020;12(6):e8824. doi: 10.7759/cureus.8824.
2. Naik BN, Pandey S, Singh C, Nirala SK, Kumar P, Verma
M. Pattern of tobacco use and perceived risk of COVID-19
following tobacco use among the COVID-19 patients of a
tertiary health care institution in Eastern India. Addict Health.
2021;13(3):194-204. doi: 10.22122/ahj.v13i3.1262.
3. Kaur G, Yogeswaran S, Muthumalage T, Rahman I.
Persistently increased systemic ACE2 activity is associated
with an increased inflammatory response in smokers with
COVID-19. Front Physiol. 2021;12:653045. doi: 10.3389/
fphys.2021.653045.
4. Emami A, Javanmardi F, Pirbonyeh N, Akbari A. Prevalence of
underlying diseases in hospitalized patients with COVID-19:
a systematic review and meta-analysis. Arch Acad Emerg
Med. 2020;8(1):e35.
5. Simons D, Shahab L, Brown J, Perski O. The association of
smoking status with SARS-CoV-2 infection, hospitalisation
and mortality from COVID-19: a living rapid evidence review
with Bayesian meta-analyses (version 12). Qeios [Preprint].
August 13, 2021. Available from: https://www.qeios.com/
read/UJR2AW.15.
6. Oakes JM, Fuchs RM, Gardner JD, Lazartigues E, Yue X.
Nicotine and the renin-angiotensin system. Am J Physiol
Regul Integr Comp Physiol. 2018;315(5):R895-R906. doi:
10.1152/ajpregu.00099.2018.
7. Alla F, Berlin I, Nguyen-Thanh V, Guignard R, Pasquereau
A, Quelet S, et al. Tobacco and COVID-19: a crisis within
a crisis? Can J Public Health. 2020;111(6):995-9. doi:
10.17269/s41997-020-00427-x.
8. Farsalinos K, Niaura R, Le Houezec J, Barbouni A, Tsatsakis
A, Kouretas D, et al. Editorial: nicotine and SARS-CoV-2:
COVID-19 may be a disease of the nicotinic cholinergic
system. Toxicol Rep. 2020;7:658-63. doi: 10.1016/j.
toxrep.2020.04.012.
9. Sankhla B, Kachhwaha K, Hussain SY, Saxena S, Sireesha
SK, Bhargava A. Genotoxic and carcinogenic effect of
gutkha: a fast-growing smokeless tobacco. Addict Health.
2018;10(1):52-63. doi: 10.22122/ahj.v10i1.537.
10. Patanavanich R, Glantz SA. Smoking is associated with
COVID-19 progression: a meta-analysis. Nicotine Tob Res.
2020;22(9):1653-6. doi: 10.1093/ntr/ntaa082.
11. Vardavas CI, Nikitara K. COVID-19 and smoking: a systematic
review of the evidence. Tob Induc Dis. 2020;18:20. doi:
10.18332/tid/119324.
12. WHO Statement: Tobacco Use and COVID-19. 2020.
Available from: https://www.who.int/news/item/11-05-2020-
who-statement-tobacco-use-and-covid-19. Accessed June 20,
2022.
13. Miyara M, Tubach F, Pourcher V, Morélot-Panzini C, Pernet J,
Haroche J, et al. Lower rate of daily smokers with symptomatic
COVID-19: a monocentric self-report of smoking habit
study. Front Med (Lausanne). 2021;8:668995. doi: 10.3389/
fmed.2021.668995.
14. Beyerstedt S, Casaro EB, Rangel É B. COVID-19: angiotensinconverting enzyme 2 (ACE2) expression and tissue
susceptibility to SARS-CoV-2 infection. Eur J Clin Microbiol
Infect Dis. 2021;40(5):905-19. doi: 10.1007/s10096-020-
04138-6.
15. Vaduganathan M, Vardeny O, Michel T, McMurray JJV,
Pfeffer MA, Solomon SD. Renin-angiotensin-aldosterone
system inhibitors in patients with COVID-19. N Engl J Med.
2020;382(17):1653-9. doi: 10.1056/NEJMsr2005760.
16. Paleiron N, Mayet A, Marbac V, Perisse A, Barazzutti H,
Brocq FX, et al. Impact of tobacco smoking on the risk of
COVID-19: a large scale retrospective cohort study. Nicotine
Tob Res. 2021;23(8):1398-404. doi: 10.1093/ntr/ntab004.
17. Samet JM. Tobacco products and the risks of SARS-CoV-2
infection and COVID-19. Nicotine Tob Res. 2020;22(12
Suppl 2):S93-S5. doi: 10.1093/ntr/ntaa187.
18. Tindle HA, Newhouse PA, Freiberg MS. Beyond smoking
cessation: investigating medicinal nicotine to prevent and
treat COVID-19. Nicotine Tob Res. 2020;22(9):1669-70. doi:
10.1093/ntr/ntaa077.
19. Boutou AK, Pitsiou G, Kontakiotis T, Kioumis I. Nicotine
treatment and smoking cessation in the era of COVID-19
pandemic: an interesting alliance. ERJ Open Res. 2020;6(3).
doi: 10.1183/23120541.00306-2020.
20. Russo P, Bonassi S, Giacconi R, Malavolta M, Tomino
C, Maggi F. COVID-19 and smoking: is nicotine the
hidden link? Eur Respir J. 2020;55(6):2001116. doi:
10.1183/13993003.01116-2020.
21. Sanchez-Ramirez DC, Mackey D. Underlying respiratory
diseases, specifically COPD, and smoking are associated with
severe COVID-19 outcomes: a systematic review and metaanalysis. Respir Med. 2020;171:106096. doi: 10.1016/j.
rmed.2020.106096.
22. Oelsner EC, Balte PP, Bhatt SP, Cassano PA, Couper D,
Folsom AR, et al. Lung function decline in former smokers
and low-intensity current smokers: a secondary data analysis
of the NHLBI Pooled Cohorts Study. Lancet Respir Med.
2020;8(1):34-44. doi: 10.1016/s2213-2600(19)30276-0.